Whole-body heat plus chemo for advanced pancreatic cancer
Part of Injuries & trauma clinical trials.
This trial tests whether adding whole-body heat treatment to standard chemotherapy can help people with advanced pancreatic cancer that has spread. It is for those who have already tried one type of chemotherapy and are looking for a new option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have metastatic pancreatic cancer confirmed by biopsy
- You have had one prior chemotherapy treatment for advanced disease
- You are in good enough health to walk and take care of yourself (ECOG score 0 or 1)
- Your height, weight, and organ function meet specific medical safety criteria
- You do not have brain metastases or serious heart, lung, or liver problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment that combines heating chemotherapy drugs and delivering them directly into the abdomen (HIPEC) with standard chemotherapy through a vein. It is for people whose pancreatic cancer has spread to the lining of the abdomen but not to other organs, and who have not had prior cancer treatment.
This study tests whether controlled whole-body heat, given along with standard cancer treatment, can help those therapies work better. It is designed for several specific advanced cancers in situations where care is focused on symptoms and tumor control.
This Phase 2 study tests a treatment that warms chemotherapy and delivers it directly into the abdomen to treat pancreatic cancer that has spread to the lining of the belly (peritoneum). You may be eligible if you completed earlier chemotherapy and your body shows signs the cancer is responding, with limited spread in the abdomen.
This trial tests a new combination of treatments for people with advanced pancreatic cancer that has spread to the liver or lungs. It includes a cancer vaccine, two chemotherapy drugs, an immunotherapy drug, and a heat-based therapy to see if it can help shrink tumors and improve outcomes.
This Phase 2 trial tests whether a device that delivers carefully timed “radiofrequency heat” through the body can slow or control metastatic (spread) pancreatic cancer. You may qualify if you have newly diagnosed metastatic pancreatic cancer and can meet safety and blood-test requirements.
This trial tests a combination approach for pancreatic cancer that has spread to a limited number of liver spots. It uses chemotherapy along with a “heat ablation” procedure (guided by ultrasound) to treat liver tumors, aiming to control the cancer more effectively.
Hear when a new Pancreatic Ductal Adenocarcinoma (mPDAC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.